The General Hospital Corporation d/b/a Massachusetts General Hospital
Grantee website Boston, Massachusetts, United StatesPurpose
to develop a new class of potentially effective antimalarial drugs by evaluating inhibitors of tRNA-synthetases, which are enzymes that are essential for survival of the malaria parasite
Grantee
Division
Global Health
Date
APRIL 2013
Region served
GLOBAL
Committed amount
$99,806
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.